Helen E. Scott
Impact in
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological diseases and metabolism
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
-
- Epigenetics and DNA Methylation 5
- Prion Diseases and Protein Misfolding 3
-
- Prostate Cancer Treatment and Research 6
- Brain Metastases and Treatment 2
- Co-authors
- V. Hugh Perry (3 shared papers)David E. Neal (10 shared papers)Delphine Boche (2 shared papers)Anne Y. Warren (7 shared papers)Colm Cunningham (2 shared papers)Ian G. Mills (9 shared papers)Charles Massie (4 shared papers)Rory Stark (5 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Neurobiology of Disease (2 papers)Molecular Cancer Therapeutics (1 paper)BMC Medical Genomics (1 paper)Cancer Cell (1 paper)
- Partner nations
- United KingdomNorwayUnited States
In The Last Decade
Helen E. Scott
19 papers receiving 901 citations
Peers
Comparison fields: 5 of 74
- Neurology 179
- Cancer Research 202
- Biological Psychiatry 28
- Pulmonary and Respiratory Medicine 315
- Molecular Biology 569
Countries citing papers authored by Helen E. Scott
This map shows the geographic impact of Helen E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Scott more than expected).
Fields of papers citing papers by Helen E. Scott
This network shows the impact of papers produced by Helen E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Scott. The network helps show where Helen E. Scott may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen E. Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 284 | |
| 2 | 2003 | 222 | |
| 3 | 2006 | 74 | |
| 4 | 2014 | 51 | |
| 5 | 2019 | 30 | |
| 6 | 2017 | 29 | |
| 7 | 2008 | 29 | |
| 8 | 2014 | 29 | |
| 9 | 2007 | 29 | |
| 10 | 2020 | 28 | |
| 11 | 2008 | 27 | |
| 12 | 2020 | 27 | |
| 13 | 2014 | 18 | |
| 14 | 2008 | 13 | |
| 15 | 1998 | 12 | |
| 16 | 2022 | 7 | |
| 17 | 2012 | 5 | |
| 18 | C-MYC induction of HES6 activates a distinct transcriptional network driving androgen insensitive prostate cancer | 2011 | 1 |
| 19 | Up-regulation of Flotillin 2 is associated with urothelial cell carcinoma progression | 2008 | 1 |
| 20 | 2025 | 0 |
About Helen E. Scott
Helen E. Scott is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 20 papers that have together received 916 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Epigenetics and DNA Methylation (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Prion Diseases and Protein Misfolding (3 papers), Brain Metastases and Treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Neurology (179 citations), Cancer Research (202 citations), Biological Psychiatry (28 citations), Pulmonary and Respiratory Medicine (315 citations) and Molecular Biology (569 citations). Helen E. Scott has collaborated with scholars based in United Kingdom, Norway and United States. Frequent co-authors include V. Hugh Perry, David E. Neal, Delphine Boche, Anne Y. Warren, Colm Cunningham, Ian G. Mills, Charles Massie, Rory Stark, Naomi L. Sharma and Antonio Ramos‐Montoya. Their work appears in journals such as Clinical Cancer Research, Neurobiology of Disease, Molecular Cancer Therapeutics, BMC Medical Genomics and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.